36C24E20Q0202.docx

DOCX document 13 KB Posted

Attached to
6505--Intent to sole source: COVID-19 Convalescent Plasma Federal contract opportunity
Solicitation number
36C24E20Q0202
Issued by
Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4

View the file

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Contract Opportunity Special Notice

PRODUCT SERVICE CODE

SUBJECT

CONTRACTING OFFICE'S

ZIP-CODE

SOLICITATION NUMBER

ARCHIVE

DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS

NAICS CODE

CONTRACTING OFFICE

ADDRESS

POINT OF CONTACT

(POC Information Automatically Filled from User Profile Unless Entered)

DESCRIPTION

See Attachment

AGENCY'S URL

URL DESCRIPTION

AGENCY CONTACT'S EMAIL

ADDRESS

EMAIL DESCRIPTION

GENERAL INFORMATION

ADDITIONAL INFORMATION

* = Required Field Contract Opportunity Special Notice Intent to sole source: COVID-19 Convalescent Plasma 15212-5319 36C24E20Q0202 N 621991 US Department of Veterans Affairs Veterans Health Administration Regional Procurement Office (RPO) East 323 North Shore Drive, Suite 500 Pittsburgh PA 15212-5319 lynn.portman@va.gov The Department of Veterans Affairs, VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, intends to negotiate on a sole source basis, pursuant to FAR 6.302-1, with Vitalant for national distribution of COVID-19 Convalescent Plasma to provide up to 1200 units of 200mL bags of COVID-19 Convalescent Plasma to support a 24-month VA clinical study using COVID-19 Convalescent Plasma to treat COVID-19 patients. COVID-19 Convalescent Plasma must meet all existing FDA guidelines (subject to change as the COVID-19 Pandemic changes) and come from an approved source. Furthermore, VA-specific requirements limit sources to vendors who can meet International Society of Blood Transfusion (ISBT) format specified in the United States Industry Consensus Standard for the Uniform Labeling of Blood and Blood Components Using ISBT 128 requirements. Vitalant is the only that can provide the plasma meeting all requirements and that can meet the VA requirement for national distribution. This is a notice of intent is not a request for competitive proposals; however, any responsible source who believes it is capable of meeting the requirement may submit a capability statement to the contracting office no later than Thursday, July 24th, 5:00 PM, EST. Interest/capability statements may be sent to Lynn Portman at lynn.portman@va.gov. No telephone responses will be accepted. A determination not to compete the proposed requirement based upon the responses to this notice is solely within the discretion of the Government.

File details come from the government source that posted it. Updated .